QuidelOrtho Corp. Stock
QuidelOrtho Corp. Stock
Heavy losses for QuidelOrtho Corp. today as the stock fell by -€0.600 (-3.850%).
With 1 Buy predictions and 2 Sell predictions the community is currently undecided on QuidelOrtho Corp..
However, we have a potential of 151.66% for QuidelOrtho Corp. as the target price of 38 € is above the current price of 15.1 €.
For the coming years our community has positive and negative things to say abot the QuidelOrtho Corp. stock. Criterium "Innovation" gathered the most positive votes but regarding "General Risks" there were negative voices in the community.
Pros and Cons of QuidelOrtho Corp. in the next few years
Pros
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
M***** P*******
Cons
?
B****
?
S********** s********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of QuidelOrtho Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| QuidelOrtho Corp. | -3.850% | -17.486% | -25.248% | -55.588% | -39.600% | -80.516% | -86.754% |
| Veeva Systems A | -0.380% | -7.092% | 6.751% | -25.488% | -18.251% | -0.641% | -27.406% |
| Thermo Fisher Scientific Inc. | -1.510% | -5.677% | -4.069% | -13.083% | -17.463% | -19.228% | 8.340% |
| Intuitive Surgical Inc | -0.530% | -2.000% | 1.210% | -6.016% | -15.363% | 95.007% | 102.280% |
Comments
QuidelOrtho (NASDAQ:QDEL) had its price target lowered by analysts at JPMorgan Chase & Co. from $26.00 to $22.00. They now have an "underweight" rating on the stock.
Show more
Ratings data for QDEL provided by MarketBeat
QuidelOrtho Co. (NASDAQ: QDEL) was upgraded by analysts at Jefferies Financial Group Inc. from a "hold" rating to a "buy" rating. They now have a $44.00 price target on the stock.
Show more
Ratings data for QDEL provided by MarketBeat
QuidelOrtho Co. (NASDAQ: QDEL) had its price target lowered by analysts at JPMorgan Chase & Co. from $38.00 to $25.00. They now have an "underweight" rating on the stock.
Show more
Ratings data for QDEL provided by MarketBeat
News
Rice Hall James Buys QuidelOrtho Stock
On Feb. 13, 2026, Rice Hall James & Associates, LLC disclosed a buy of QuidelOrtho (NASDAQ:QDEL) in the fourth quarter.
An SEC filing dated Feb. 13, 2026, shows Rice Hall James & Associates, LLC
QuidelOrtho Corp Director Purchases 10k Shares as CFO Retires
Matthew Strobeck, a Board Director at QuidelOrtho Corp. (NASDAQ:QDEL), reported the purchase of 10,000 common shares on Feb. 13, 2026, for a total transaction value of ~$240,000, as disclosed in a
Why One Value Fund Just Bought $30 Million of a Diagnostics Stock Down 90% From Pandemic-Era Highs
On November 14, New York City-based Newtyn Management disclosed a purchase of 994,332 shares of QuidelOrtho Corporation (QDEL), increasing its stake by approximately $30.4 million.
According to a